Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Hypertension. 2021 Mar 1;77(4):1212–1222. doi: 10.1161/HYPERTENSIONAHA.120.16175

Figure 3.

Figure 3.

Targeted metabolomics analysis of plasma samples taken before and after chronic supplementation with sodium nitrite or placebo from a subset of subjects (N=8–10/group). 3-Dimensional partial least squares-discriminant analysis depicting the differential response to treatment (expressed as a fold change from baseline within each group) in the sodium nitrite and placebo-treated groups (A). Hierarchical clustering analysis of top 25 metabolites differentially altered by treatment between sodium nitrite and placebo-treated groups (each box represents a fold change from baseline for a given subject) (B).